日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combination of racotumomab immunotherapy with programmed death-1 blockade in a preclinical model of non-small cell lung cancer

在非小细胞肺癌的临床前模型中,将racotumomab免疫疗法与程序性死亡受体1(PD-1)阻断疗法联合应用

Valeria I Segatori ,Selene Rojo ,Cynthia A Gulino ,Carla S Capobianco ,Gretel M Ferreira ,Martina Crispo ,Ignacio A Demarco ,Eduardo Spitzer ,Mariano R Gabri ,Daniel F Alonso

Vasopressin Analog [V4Q5]dDAVP Exerts Cooperative Anticancer Effects in Combination With Low-Dose 5-Fluorouracil on Aggressive Colorectal Cancer Models

加压素类似物 [V4Q5]dDAVP 与低剂量 5-氟尿嘧啶联合使用对侵袭性结直肠癌模型发挥协同抗癌作用

Natasha T Sobol, Luisina M Solerno, Candela Llavona, Daniel F Alonso, Juan Garona

Propranolol blocks osteosarcoma cell cycle progression, inhibits angiogenesis and slows xenograft growth in combination with cisplatin-based chemotherapy

普萘洛尔与顺铂化疗联合使用可阻断骨肉瘤细胞周期进程、抑制血管生成并减缓异种移植瘤的生长

Luisina M Solernó, Natasha T Sobol, María F Gottardo, Carla S Capobianco, Maximiliano R Ferrero, Liliana Vásquez, Daniel F Alonso, Juan Garona

Preclinical Efficacy and Toxicology Evaluation of RAC1 Inhibitor 1A-116 in Human Glioblastoma Models

RAC1 抑制剂 1A-116 在人类胶质母细胞瘤模型中的临床前疗效和毒理学评估

Georgina A Cardama, Julian Maggio, Lucas Valdez Capuccino, Nazareno Gonzalez, Valentina Matiller, Hugo H Ortega, German R Perez, Ignacio A Demarco, Eduardo Spitzer, Daniel E Gomez, Pablo Lorenzano Menna, Daniel F Alonso

Preclinical Efficacy of [V4 Q5 ]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer

第二代加压素类似物 [V4 Q5 ]dDAVP 对结直肠癌转移扩散和肿瘤相关血管生成的临床前疗效

Juan Garona, Natasha T Sobol, Marina Pifano, Valeria I Segatori, Daniel E Gomez, Giselle V Ripoll, Daniel F Alonso

Aberrant O-glycosylation modulates aggressiveness in neuroblastoma

异常 O-糖基化调节神经母细胞瘤的侵袭性

Hector A Cuello, Valeria I Segatori, Marina Albertó, Cynthia A Gulino, Rosario Aschero, Sandra Camarero, Laura Galluzzo Mutti, Kevin Madauss, Daniel F Alonso, Fabiana Lubieniecki, Mariano R Gabri

Peptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor Cells

加压素 V2 受体肽激动剂可降低人类肺癌和前列腺肿瘤细胞中神经内分泌标志物的表达和肿瘤生长

Marina Pifano, Juan Garona, Carla S Capobianco, Nazareno Gonzalez, Daniel F Alonso, Giselle V Ripoll

The novel desmopressin analogue [V4Q5]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models

新型去氨加压素类似物 [V4Q5]dDAVP 可抑制血管加压素 2 型受体表达乳腺癌模型中的血管生成、肿瘤生长和转移

Juan Garona, Marina Pifano, Ulises D Orlando, Maria B Pastrian, Nancy B Iannucci, Hugo H Ortega, Ernesto J Podesta, Daniel E Gomez, Giselle V Ripoll, Daniel F Alonso

Proapoptotic and antiinvasive activity of Rac1 small molecule inhibitors on malignant glioma cells

Rac1小分子抑制剂对恶性胶质瘤细胞的促凋亡和抗侵袭活性

Georgina A Cardama, Nazareno Gonzalez, Matias Ciarlantini, Lucia Gandolfi Donadío, María Julieta Comin, Daniel F Alonso, Pablo Lorenzano Menna, Daniel E Gomez

Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines

采用合理设计方法在高度侵袭性乳腺癌细胞系中进行新型 Rac1-GEF 信号抑制剂的临床前开发

Georgina A Cardama, Maria J Comin, Leandro Hornos, Nazareno Gonzalez, Lucas Defelipe, Adrian G Turjanski, Daniel F Alonso, Daniel E Gomez, Pablo Lorenzano Menna